Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance
Mina Komuta
Clin Mol Hepatol. 2022;28(3):396-407.   Published online 2022 Jan 14     DOI: https://doi.org/10.3350/cmh.2021.0287
Citations to this article as recorded by Crossref logo
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management
Liangtao Ye, Julia S. Schneider, Najib Ben Khaled, Peter Schirmacher, Carolin Seifert, Lea Frey, Yulong He, Andreas Geier, Enrico N. De Toni, Changhua Zhang, Florian P. Reiter
Liver Cancer.2024; 13(1): 6.     CrossRef
UBA3 promotes the occurrence and metastasis of intrahepatic cholangiocarcinoma through MAPK signaling pathway
Huhu Zhang, Jiahua Yang, Qinghang Song, Xiaoyan Ding, Fulin Sun, Lina Yang
Acta Biochimica et Biophysica Sinica.2024; 56(2): 199.     CrossRef
Intrahepatic cholangiocarcinoma: histological diversity and the role of the pathologist
Mina Komuta
Journal of Liver Cancer.2024; 24(1): 17.     CrossRef
Surgical interpretation of the WHO subclassification of intrahepatic cholangiocarcinoma: a narrative review
Masayuki Akita, Hiroaki Yanagimoto, Daisuke Tsugawa, Yoh Zen, Takumi Fukumoto
Surgery Today.2024;[Epub]     CrossRef
Targeted therapies in advanced biliary malignancies: a clinical review
Udhayvir S. Grewal, Shiva J. Gaddam, Muhammad S. Beg, Timothy J. Brown
Expert Review of Anticancer Therapy.2024; 24(9): 869.     CrossRef
Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping
Hee Seung Lee, Dai Hoon Han, Kyungjoo Cho, Soo Been Park, Chanyang Kim, Galam Leem, Dawoon E. Jung, Soon Sung Kwon, Chul Hoon Kim, Jung Hyun Jo, Hye Won Lee, Si Young Song, Jun Yong Park
Nature Communications.2023;[Epub]     CrossRef
Establishment and characterization of a new intrahepatic cholangiocarcinoma cell line, ICC-X3
Hao Xu, Wei Luo, Zhenjie Zhao, Xin Miao, Changpeng Chai, Jinjing Hu, Huan Tang, Hui Zhang, Wence Zhou
Human Cell.2023; 36(2): 854.     CrossRef
A Case of Prostatic Metastasis from Intrahepatic Cholangiocarcinoma: An Extremely Rare Event
Sanathan Aiyadurai, Tulika Garg, Tass Sayeed, Zainab Shahbaz, Idowu O Adewole, Enoh Nguty Nkeng, Abia Joseph, Datiobong Udoeyop, Yusra Qamar, Aadil Khan
Cureus.2023;[Epub]     CrossRef
Non-Inflamed Tumor Microenvironment and Methylation/Downregulation of Antigen-Presenting Machineries in Cholangiocarcinoma
Naoshi Nishida, Tomoko Aoki, Masahiro Morita, Hirokazu Chishina, Masahiro Takita, Hiroshi Ida, Satoru Hagiwara, Yasunori Minami, Kazuomi Ueshima, Masatoshi Kudo
Cancers.2023; 15(8): 2379.     CrossRef
Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies
Xianzhe Yu, Lingling Zhu, Ting Wang, Jiang Chen
Frontiers in Immunology.2023;[Epub]     CrossRef
Clinicopathological, etiological and molecular characteristics of intrahepatic cholangiocarcinoma subtypes classified by mucin production and immunohistochemical features
Yi Chen, Xiaoling Liu, Liyun Huang, Lihong Chen, Bin Wang
Expert Review of Molecular Diagnostics.2023; 23(5): 445.     CrossRef
MCM6 promotes intrahepatic cholangiocarcinoma progression by upregulating E2F1 and enhancing epithelial–mesenchymal transition
Chongqing Gao, Jing Li, Fuling Zeng, Lijuan Wang, Kaiyun Chen, Dong Chen, Jian Hong, Chen Qu
Carcinogenesis.2023; 44(4): 279.     CrossRef
Novel cell subtypes of SPP1 + S100P+, MS4A1-SPP1 + S100P+ were key subpopulations in intrahepatic cholangiocarcinoma
Zixue Xuan, Linqing Liu, Guobing Zhang, Xiaowei Zheng, Jinying Jiang, Kai Wang, Ping Huang
Biochimica et Biophysica Acta (BBA) - General Subjects.2023; 1867(9): 130420.     CrossRef
Liver Transplantation for Incidental Cholangiocarcinoma or Combined Hepatocellular Carcinoma/Cholangiocarcinoma—Own Experiences and Review of the Literature
Laura Schwenk, Oliver Rohland, Aladdin Ali-Deeb, Felix Dondorf, Utz Settmacher, Falk Rauchfuß
Cancers.2023; 15(14): 3609.     CrossRef
Beyond the Lab and Into the Hospital: An Outlook on the Clinical Utility of Spatial Omics Technologies
Dean M. Pucciarelli, Benjamin Y. Lu, Inti Zlobec, Marcello DiStasio
GEN Biotechnology.2023; 2(5): 360.     CrossRef
Targeted mutation-based therapy for intrahepatic cholangiocarcinoma
Facai Yang, Yinghe Qiu, Bin Yi
Hepatoma Research.2023;[Epub]     CrossRef
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions
Rocio I R Macias, Vincenzo Cardinale, Timothy J Kendall, Matias A Avila, Maria Guido, Cedric Coulouarn, Chiara Braconi, Adam E Frampton, John Bridgewater, Diletta Overi, Stephen P Pereira, Marco Rengo, Jakob N Kather, Angela Lamarca, Federica Pedica, Alej
Gut.2022; : gutjnl-2022-327099.     CrossRef